Avacta Group (Avacta Group) Days Inventory : 74.86 (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Avacta Group Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Avacta Group's Average Total Inventories for the six months ended in Dec. 2023 was $3.56 Mil. Avacta Group's Cost of Goods Sold for the six months ended in Dec. 2023 was $8.69 Mil. Hence, Avacta Group's Days Inventory for the six months ended in Dec. 2023 was 74.86.

The historical rank and industry rank for Avacta Group's Days Inventory or its related term are showing as below:

AVCTF' s Days Inventory Range Over the Past 10 Years
Min: 64.86 Med: 104.43 Max: 294.01
Current: 74.18

During the past 13 years, Avacta Group's highest Days Inventory was 294.01. The lowest was 64.86. And the median was 104.43.

AVCTF's Days Inventory is ranked better than
80.65% of 651 companies
in the Biotechnology industry
Industry Median: 189.69 vs AVCTF: 74.18

Avacta Group's Days Inventory declined from Dec. 2022 (79.07) to Dec. 2023 (74.86).

Inventory Turnover measures how fast the company turns over its inventory within a year. Avacta Group's Inventory Turnover for the six months ended in Dec. 2023 was 2.44.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Avacta Group's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.25.

Avacta Group Days Inventory Historical Data

The historical data trend for Avacta Group's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avacta Group Days Inventory Chart

Avacta Group Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Jul18

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

70.05

81.72

86.72

142.90

63.90

Avacta Group Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial															102.36	148.74	79.07	82.97	74.86

Competitive Comparison of Avacta Group's Days Inventory

For the Biotechnology subindustry, Avacta Group's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Avacta Group's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Avacta Group's Days Inventory distribution charts can be found below:

* The bar in red indicates where Avacta Group's Days Inventory falls into.

Avacta Group Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Avacta Group's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.048	+	3.272)	/	2 )	/	15.194	*	365
=	2.66					/	15.194	*	365
=	63.90

Avacta Group's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (3.854	+	3.272)	/	2 )	/	8.686	*	365 / 2
=	3.563					/	8.686	*	365 / 2
=	74.86

Avacta Group (OTCPK:AVCTF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Avacta Group's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	8.686	/	3.563
	=	2.44

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Avacta Group's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	3.563	/	14.377
	=	0.25

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Avacta Group Days Inventory Related Terms

Thank you for viewing the detailed overview of Avacta Group's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Avacta Group (Avacta Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avacta Group PLC (OTCPK:AVCTF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

AVCT:UK RTQ1:Germany

Address

Unit 20, Ash Way, Thorp Arch Estate, West Yorkshire, Wetherby, GBR, LS23 7FA

Website

https://www.avacta.com

Avacta Group PLC is a United Kingdom-based biotechnology company. The company offers its products through three segments that are Diagnostics, Therapeutics, and Animal Health. The company is developing novel cancer immunotherapies combining its two proprietary platforms Affimer biotherapeutics and precision tumor-targeted chemotherapy. The company operates in the United Kingdom, France, South Korea, Rest of Europe, Asia, and North America.